Ruifu Chemical Supply Telmisartan Intermediates With High Purity
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl)benzoic Acid CAS 7148-03-0
Telmisartan Benzimidazole Acid CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
| Chemical Name |
Methyl 2-[4-(Bromomethyl)phenyl]benzoate |
| Synonyms |
2-[4-(Bromomethyl)phenyl]benzoic Acid Methyl Ester; Methyl 4'-(Bromomethyl)biphenyl-2-Carboxylate; 4'-(Bromomethyl)biphenyl-2-Carboxylic Acid Methyl Ester |
| CAS Number |
114772-38-2 |
| CAT Number |
RF-PI1879 |
| Stock Status |
In Stock, Production Capacity 150MT/Year |
| Molecular Formula |
C15H13BrO2 |
| Molecular Weight |
305.17 |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
White to Light Yellow Crystalline Powder |
| Clarity |
Colorless and Transparent, Without Foreign Substances |
| Purity / Analysis Method |
>99.0% (HPLC) |
| Melting Point |
48.0~57.0℃ |
| Loss on Drying |
<0.50% |
| Residue on Ignition |
<0.20% |
| Single Impurity |
<0.50% |
| Total Impurities |
<1.00% |
| Heavy Metals (as Pb) |
<20ppm |
| Proton NMR Spectrum |
Conforms to Structure |
| Test Standard |
Enterprise Standard |
| Usage |
Intermediate of Telmisartan (CAS: 144701-48-4)
|
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
Methyl 2-[4-(Bromomethyl)phenyl]benzoate (CAS: 114772-38-2), pharmaceutical intermediates, used in the production of sartan series APIs. Methyl 2-[4-(Bromomethyl)phenyl]benzoate is an intermediate of Telmisartan (CAS: 144701-48-4). Telmisartan is an angiotensin II receptor blocker (ARB) that has high affinity for the angiotensin II receptor type 1 (AT1).Telmisartan interferes with the binding of angiotensin II to AT1 receptors in vascular smooth muscle and thus inhibits the vasoconstricting action of angiotensin II. Telmisartan was originally formulated by the German pharmaceutical company Boehringer Ingelheim. Telmisartan was launched in the US for the treatment of hypertension. Used alone or in combination with other classes of antihypertensives for the treatment of hypertension.